drugset / Trial / NCT04086719
An Investigational Study to Determine the Drug Level Profile of BMS-986165 in Healthy Male Volunteers Following Transporter Inhibition.
Non-randomizedCrossoverOpen-labelTreatment
Summary
Study of what the body does to drug BMS-986165 when it is taken together with pyrimethamine
Timeline
- Start
- 2019-09-12
- Primary completion
- 2019-10-29
- Completion
- 2019-10-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CRAVACITINIB | Small molecule | — | Oral |
| Subject | pyrimethamine | Small molecule | — | Oral |
Indications
No indication recorded.